Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined. [provided by RefSeq, Jul 2008].
Uemasu, Tanabe, Tanimura, Hasegawa, Mizutani, Hamakawa, Sato, Ogawa, Thomas, Ikegami, Muro, Hirai, Sato: "Serine Protease Imbalance in the Small Airways and Development of Centrilobular Emphysema in Chronic Obstructive Pulmonary Disease." in: American journal of respiratory cell and molecular biology, Vol. 63, Issue 1, pp. 67-78, (2020) (PubMed).
Kapadia, Ghosh, Grass, Diamandis: "Human kallikrein 13 involvement in extracellular matrix degradation." in: Biochemical and biophysical research communications, Vol. 323, Issue 3, pp. 1084-90, (2004) (PubMed).
Petraki, Gregorakis, Papanastasiou, Karavana, Luo, Diamandis: "Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues." in: Prostate cancer and prostatic diseases, Vol. 6, Issue 3, pp. 223-7, (2003) (PubMed).
Chang, Yousef, Scorilas, Grass, Sismondi, Ponzone, Diamandis: "Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer." in: British journal of cancer, Vol. 86, Issue 9, pp. 1457-64, (2002) (PubMed).